196 related articles for article (PubMed ID: 26457783)
21. Modified enzyme multiplied immunoassay technique of methotrexate assay to improve sensitivity and reduce cost.
Shi X; Gao H; Li Z; Li J; Liu Y; Li L; Zhang Q
BMC Pharmacol Toxicol; 2019 Jan; 20(1):3. PubMed ID: 30626430
[TBL] [Abstract][Full Text] [Related]
22. Selected performance characteristics of the Roche Elecsys testosterone II assay on the Modular analytics E 170 analyzer.
Owen WE; Rawlins ML; Roberts WL
Clin Chim Acta; 2010 Aug; 411(15-16):1073-9. PubMed ID: 20385114
[TBL] [Abstract][Full Text] [Related]
23. Performance characteristics of the ARK diagnostics gabapentin immunoassay.
Juenke JM; Wienhoff KA; Anderson BL; McMillin GA; Johnson-Davis KL
Ther Drug Monit; 2011 Aug; 33(4):398-401. PubMed ID: 21654348
[TBL] [Abstract][Full Text] [Related]
24. [Performance evaluation of affinity column mediated immunometric assay for tacrolimus].
Chung JW; An D; Song J; Chung HJ; Park HI; Lee W; Chun S; Min WK
Korean J Lab Med; 2009 Oct; 29(5):415-22. PubMed ID: 19893350
[TBL] [Abstract][Full Text] [Related]
25. Performance Evaluation of an Automated Fentanyl Immunoassay.
Tang MS; Lloyd M; Williams M; Farnsworth CW; Budelier MM
J Appl Lab Med; 2021 Sep; 6(5):1192-1201. PubMed ID: 34263303
[TBL] [Abstract][Full Text] [Related]
26. How low can you go? Analytical performance of five automated testosterone immunoassays.
La'ulu SL; Kalp KJ; Straseski JA
Clin Biochem; 2018 Aug; 58():64-71. PubMed ID: 29763574
[TBL] [Abstract][Full Text] [Related]
27. Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry Analyzers.
Verougstraete N; Stove V; Verstraete AG; Oyaert M
Ther Drug Monit; 2022 Apr; 44(2):335-339. PubMed ID: 34985848
[TBL] [Abstract][Full Text] [Related]
28. The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS/MS gold standard.
Abou El Hassan M; Colantonio D; Likhodii S; Nassar BA
Clin Biochem; 2021 Jul; 93():99-103. PubMed ID: 33844982
[TBL] [Abstract][Full Text] [Related]
29. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of specificity of aldosterone measurement in human serum and plasma using 2D-LC-MS/MS and comparison with commercial immunoassays.
Ray JA; Kushnir MM; Palmer J; Sadjadi S; Rockwood AL; Meikle AW
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 970():102-7. PubMed ID: 25247493
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid.
Castoldi S; Cozzi V; Baldelli S; Fucile S; Clementi E; Cattaneo D
Ther Drug Monit; 2018 Feb; 40(1):140-143. PubMed ID: 29324625
[TBL] [Abstract][Full Text] [Related]
32. Effect of Carbamazepine 10, 11-Epoxide on Serum Carbamazepine Measurement Using a New CMIA Assay: Comparison of Values Obtained by Using PETINIA, CEDIA and Liquid Chromatography Combined with Tandem Mass Spectrometry.
Dasgupta A; Davis B; Slawson MH; Johnson-Davis KL
Ann Clin Lab Sci; 2016 May; 46(3):242-6. PubMed ID: 27312546
[TBL] [Abstract][Full Text] [Related]
33. Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution.
Liu TW; Yeh ML; Huang CF; Lin IL; Huang JF; Dai CY; Chen YL; Chuang WL; Yu ML
Kaohsiung J Med Sci; 2015 Jan; 31(1):26-33. PubMed ID: 25600917
[TBL] [Abstract][Full Text] [Related]
34. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
[TBL] [Abstract][Full Text] [Related]
35. Analytical interference in the therapeutic drug monitoring of methotrexate.
Oudart JB; Marquet B; Feliu C; Gozalo C; Djerada Z; Millart H
Ann Biol Clin (Paris); 2016 Jun; 74(3):333-7. PubMed ID: 27101631
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a straightforward and rapid method for the therapeutic drug monitoring of digitoxin by LC-MS/MS.
Bremer-Streck S; Kiehntopf M; Ihle S; Boeer K
Clin Biochem; 2013 Nov; 46(16-17):1728-33. PubMed ID: 23954852
[TBL] [Abstract][Full Text] [Related]
37. Experience with the first fully automated chemiluminescence immunoassay for the quantification of 1α, 25-dihydroxy-vitamin D.
van Helden J; Weiskirchen R
Clin Chem Lab Med; 2015 Apr; 53(5):761-70. PubMed ID: 25274943
[TBL] [Abstract][Full Text] [Related]
38. Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods.
De BK; Jimenez E; De S; Sawyer JC; McMillin GA
Clin Chim Acta; 2009 Dec; 410(1-2):25-30. PubMed ID: 19751714
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the CEDIA and MEIA assays for measurement of tacrolimus in organ transplant recipients.
Liang SL; Breaud A; Dunn W; Clarke W
Clin Chim Acta; 2008 Oct; 396(1-2):1-6. PubMed ID: 18606158
[TBL] [Abstract][Full Text] [Related]
40. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
